These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 9232522)

  • 41. Effects of some non-ionic surfactants on transepithelial permeability in Caco-2 cells.
    Dimitrijevic D; Shaw AJ; Florence AT
    J Pharm Pharmacol; 2000 Feb; 52(2):157-62. PubMed ID: 10714945
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drug-transporter mediated interactions between anthelminthic and antiretroviral drugs across the Caco-2 cell monolayers.
    Kigen G; Edwards G
    BMC Pharmacol Toxicol; 2017 May; 18(1):20. PubMed ID: 28468637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correlation between epithelial toxicity and surfactant structure as derived from the effects of polyethyleneoxide surfactants on caco-2 cell monolayers and pig nasal mucosa.
    Ekelund K; Osth K; Påhlstorp C; Björk E; Ulvenlund S; Johansson F
    J Pharm Sci; 2005 Apr; 94(4):730-44. PubMed ID: 15682384
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytotoxic effect of As(III) in Caco-2 cells and evaluation of its human intestinal permeability.
    Laparra JM; Vélez D; Barberá R; Granero L; Polache A; Montoro R; Farré R
    Toxicol In Vitro; 2006 Aug; 20(5):658-63. PubMed ID: 16472965
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Polysorbate 80 and Cremophor EL micelles deaggregate and solubilize nystatin at the core-corona interface.
    Croy SR; Kwon GS
    J Pharm Sci; 2005 Nov; 94(11):2345-54. PubMed ID: 16200548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification.
    Incecayir T; Tsume Y; Amidon GL
    Mol Pharm; 2013 Mar; 10(3):958-66. PubMed ID: 23327720
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transport of Val-Leu-Pro-Val-Pro in human intestinal epithelial (Caco-2) cell monolayers.
    Lei L; Sun H; Liu D; Liu L; Li S
    J Agric Food Chem; 2008 May; 56(10):3582-6. PubMed ID: 18442243
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
    Dahan A; Amidon GL
    Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Absorption and transport of 6 coumarins isolated from the roots of Angelica pubescens f. biserrata in human Caco-2 cell monolayer model].
    Yang XW; Guo QM; Wang Y
    Zhong Xi Yi Jie He Xue Bao; 2008 Apr; 6(4):392-8. PubMed ID: 18405608
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determination of the investigational anti-cancer drug 5,6-dimethylxanthenone-4-acetic acid and its acyl glucuronide in Caco-2 monolayers by liquid chromatography with fluorescence detection: application to transport studies.
    Zhou S; Feng X; Kestell P; Baguley BC; Paxton JW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 809(1):87-97. PubMed ID: 15282097
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of dexloxiglumide in vitro biopharmaceutical properties and active transport.
    Tolle-Sander S; Grill A; Joshi H; Kapil R; Persiani S; Polli JE
    J Pharm Sci; 2003 Oct; 92(10):1968-80. PubMed ID: 14502537
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Absorption of CH330331, a novel 4-anilinoquinazoline inhibitor of epidermal growth factor receptor tyrosine kinase: comparative studies using in vitro, in situ and in vivo models.
    Sun H; Bi H; Huang M; Liu D; Qin Z
    Biopharm Drug Dispos; 2010 Nov; 31(8-9):486-94. PubMed ID: 20936649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prodrug approach for alphaIIbbeta3-peptidomimetic antagonists to enhance their transport in monolayers of a human intestinal cell line (Caco-2): comparison of in vitro and in vivo data.
    Kamm W; Raddatz P; Gante J; Kissel T
    Pharm Res; 1999 Oct; 16(10):1527-33. PubMed ID: 10554093
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transport of a Novel Angiotensin-I-Converting Enzyme Inhibitory Peptide Ala-His-Leu-Leu Across Human Intestinal Epithelial Caco-2 Cells.
    Li Y; Zhao J; Liu X; Xia X; Wang Y; Zhou J
    J Med Food; 2017 Mar; 20(3):243-250. PubMed ID: 28296590
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Evaluation of cytotoxicity of surfactants used in self-micro emulsifying drug delivery systems and their effects on paracellular transport in Caco-2 cell monolayer.
    Ujhelyi Z; Fenyvesi F; Váradi J; Fehér P; Kiss T; Veszelka S; Deli M; Vecsernyés M; Bácskay I
    Eur J Pharm Sci; 2012 Oct; 47(3):564-73. PubMed ID: 22841998
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanistic studies on surfactant-induced membrane permeability enhancement.
    Xia WJ; Onyuksel H
    Pharm Res; 2000 May; 17(5):612-8. PubMed ID: 10888315
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transport mechanisms of the large neutral amino acid L-phenylalanine in the human intestinal epithelial caco-2 cell line.
    Berger V; Larondelle Y; Trouet A; Schneider YJ
    J Nutr; 2000 Nov; 130(11):2780-8. PubMed ID: 11053521
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of basolateral-to-apical transepithelial transport of cadmium in intestinal TC7 cell monolayers.
    Carrière P; Mantha M; Champagne-Paradis S; Jumarie C
    Biometals; 2011 Oct; 24(5):857-74. PubMed ID: 21424617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kinetics of manganese transport and gene expressions of manganese transport carriers in Caco-2 cell monolayers.
    Li X; Xie J; Lu L; Zhang L; Zhang L; Zou Y; Wang Q; Luo X; Li S
    Biometals; 2013 Dec; 26(6):941-53. PubMed ID: 23996061
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
    Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
    J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.